← Open Payments lookup

LAURA MUNIZ: Open Payments

NPI 1851870505 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$407 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $407

Food & beverage: $407
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$149
Novo Nordisk Inc4$74
Medtronic, Inc.1$41
GlaxoSmithKline, LLC.2$32
Sumitomo Pharma America, Inc.1$28
Lilly USA, LLC1$27
Ardelyx, Inc.1$20
Exact Sciences Corporation1$17
Phathom Pharmaceuticals, Inc.1$16

Products named: AIRSUPRA, Wegovy, VECTRIS SURESCAN, SHINGRIX, GEMTESA, MOUNJARO, BREZTRI, IBSRELA.

Industry payments across TX — which companies pay providers there.